Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Pharmaceutical Research|March 23, 2024
Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric PopulationsFarzaneh Maleki, Cheng Chang, Vivek S Purohit, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 16, 2017
Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid BetaTatiana Karelina, Oleg Demin, Oleg Demin, et al.
Plos One|February 7, 2018
A mathematical model of multisite phosphorylation of tau proteinAlexander Stepanov, Tatiana Karelina, Nikolai Markevich, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2019
Evaluation of QT Liability for PF-05251749 in the Presence of Potential Circadian Rhythm ModificationYeamin Huh, Danny Chen, Steve Riley, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 1, 2024
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERMYuchen Wang, Luke Fostvedt, Jessica Wojciechowski, et al.
Plos One|March 2, 2018
Correction: A mathematical model of multisite phosphorylation of tau proteinAlexander Stepanov, Tatiana Karelina, Nikolai Markevich, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2024
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseasesFarzaneh Maleki, Elias Clark, Christopher Banfield, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
Clinical Pharmacology and Therapeutics|March 26, 2025
Impact of Model-Informed Drug Development on Drug Development Cycle Times and Clinical Trial CostVaishali Sahasrabudhe, Timothy Nicholas, Gianluca Nucci, et al.
Clinical Pharmacology in Drug Development|September 1, 2022
Population Pharmacokinetics of Oral Brepocitinib in Healthy Volunteers and PatientsJim H Hughes, Ruolun Qiu, Christopher Banfield, et al.
Pageof 5